Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLATIRAMER Cause Multiple sclerosis relapse? 3,695 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 3,695 reports of Multiple sclerosis relapse have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 8.0% of all adverse event reports for GLATIRAMER.

3,695
Reports of Multiple sclerosis relapse with GLATIRAMER
8.0%
of all GLATIRAMER reports
6
Deaths
718
Hospitalizations

How Dangerous Is Multiple sclerosis relapse From GLATIRAMER?

Of the 3,695 reports, 6 (0.2%) resulted in death, 718 (19.4%) required hospitalization, and 5 (0.1%) were considered life-threatening.

Is Multiple sclerosis relapse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 3,695 reports have been filed with the FAERS database.

What Other Side Effects Does GLATIRAMER Cause?

Injection site pain (5,003) Drug ineffective (3,321) Injection site reaction (3,317) Multiple sclerosis (2,596) Injection site erythema (2,560) Fatigue (2,408) Dyspnoea (2,364) Injection site mass (2,172) Injection site swelling (1,836) Fall (1,701)

What Other Drugs Cause Multiple sclerosis relapse?

DIMETHYL (6,852) FINGOLIMOD (6,728) NATALIZUMAB (6,478) INTERFERON BETA-1A (5,931) TERIFLUNOMIDE (4,745) DALFAMPRIDINE (3,322) OCRELIZUMAB (2,326) OFATUMUMAB (1,525) INTERFERON BETA-1B (1,229) PEGINTERFERON BETA-1A (945)

Which GLATIRAMER Alternatives Have Lower Multiple sclerosis relapse Risk?

GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR GLATIRAMER vs GLEEVEC GLATIRAMER vs GLICLAZIDE GLATIRAMER vs GLIMEPIRIDE GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE

Related Pages

GLATIRAMER Full Profile All Multiple sclerosis relapse Reports All Drugs Causing Multiple sclerosis relapse GLATIRAMER Demographics